Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The limitations of targeting MEK signalling in Glioblastoma therapy.
Sci Rep. 2020 May 4;10(1):7401. doi: 10.1038/s41598-020-64289-6.
Sci Rep. 2020.
PMID: 32366879
Free PMC article.
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy.
Westhoff MA, Schuler-Ortoli M, Zerrinius D, Hadzalic A, Schuster A, Strobel H, Scheuerle A, Wong T, Wirtz CR, Debatin KM, Peraud A.
Westhoff MA, et al. Among authors: hadzalic a.
Pharmaceuticals (Basel). 2022 Jan 14;15(1):91. doi: 10.3390/ph15010091.
Pharmaceuticals (Basel). 2022.
PMID: 35056150
Free PMC article.
Item in Clipboard
Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma.
Xu P, Westhoff MA, Hadzalic A, Debatin KM, Winiarski L, Oleksyszyn J, Wirtz CR, Knippschild U, Burster T.
Xu P, et al. Among authors: hadzalic a.
ACS Omega. 2022 Feb 8;7(7):5929-5936. doi: 10.1021/acsomega.1c06169. eCollection 2022 Feb 22.
ACS Omega. 2022.
PMID: 35224353
Free PMC article.
Item in Clipboard
Cite
Cite